The UK Investor Magazine Podcast was joined by Nicolas Serandour, CEO of Advanced Oncotherapy, to discuss the latest progress in democratising Proton Beam Therapy.
Nicolas explains the benefits of Proton Beam Therapy when compared to radiotherapy in treating certain forms of cancers and how Advanced Oncotherapy is setting out to make the treatment available to more patients.
There is also consideration paid to Advanced Oncotherapy's revenue channels and recent technical trading update.
Hosted on Acast. See acast.com/privacy for more information.
UK Investor Magazine